Cedric Bellanger

Cedric Bellanger, listed as board member, appears in our data through filings on Theraclion shares, published by AMF. We count 7 filings; the first trade dates from 1 March 2022 and the latest from 8 June 2026.

In open-market terms, that means 1 purchase worth €25k on one side and 4 sales worth €44k on the other. Sales outweigh purchases by €19k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 1 option exercise. So far in 2026, the count stands at no purchases and 4 sales.

On 11 June 2026 came the latest disclosure, an open-market sale for €20k in Theraclion. The clock since the last published purchase (7 March 2022) now reads 1,685 days. Between a trade and the moment it shows up on AMF, the median delay is 6 days. The legal deadline for notifying a trade is three business days (MAR article 19). Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by AMF. They describe what insiders did and are not a recommendation.